References
- Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389(10082):1941–1952. doi: 10.1016/S0140-6736(17)30866-8.
- Wuyts WA, Wijsenbeek M, Bondue B, et al. Idiopathic pulmonary fibrosis: best practice in monitoring and managing a relentless fibrotic disease. Respiration. 2020;99(1):73–82. doi: 10.1159/000504763.
- Vancheri C, Du Bois RM. A progression-free end-point for idiopathic pulmonary fibrosis trials: lessons from cancer. Eur Respir J. 2013;41(2):262–269. doi: 10.1183/09031936.00115112.
- Tzouvelekis A, Karampitsakos T, Gomatou G, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. A retrospective multicenter study in Greece. Pulm Pharmacol Ther. 2020;60:101880. doi: 10.1016/j.pupt.2019.101880.
- Tale S, Ghosh S, Meitei SP, et al. Post-COVID-19 pneumonia pulmonary fibrosis. QJM. 2020;113(11):837–838. doi: 10.1093/qjmed/hcaa255.
- Lee JH, Koh J, Jeon YK, et al. An integrated radiologic-pathologic understanding of COVID-19 pneumonia. Radiology. 2023;306(2):e222600. doi: 10.1148/radiol.222600.
- Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389:1941–1952. doi:10.1016/S0140-6736(17)30866-8
- Guidelines for the diagnosis and treatment of idiopathic pulmonary (interstitial) fibrosis (draft). Chin J Tubercu Respi Dis. 2002;07:6–8. https://kns.cnki.net/kcms2/article/abstract?v=NR7yonmY8oOF09qS-KpqZZBrH0cGFtK7doJdbH3wbe48gvZ8ePUYmliWlpyuAnSLbUhJM9YuiLIDZlC7k29bnzOqyVOeOWdSTosn8rgkuX-YXpqUurr5XKNn14uqhZUzWCPmlRFg7W0=&uniplatform=NZKPT&language=CHS
- Li H, Jiang Y, He FC. Recent development of metabonomics and its applications in clinical research. Hereditas. 2008;30(4):389–399. doi: 10.3724/SP.J.1005.2008.00389.
- Nobeli I, Thornton JM. A bioinformatician’s view of the metabolome. Bioessays. 2006;28(5):534–545. doi: 10.1002/bies.20414.
- Huang XC, Xu SL, Guo JM, et al. Application and thinking of metabonomics in some scientific problems of traditional chinese medicine. Chin Tradit Herb Drugs. 2014;45:147–153.https://kns.cnki.net/kcms2/article/abstract?v=NR7yonmY8oMdsvNInENbzi4W24eyFvv6dZQABIr8c9JVJdDGOpNeXmksYlChH8LsOSdmkf5ZtL4bt-O1EI4TxvjEEPE_uUd8gQGNZJ9mW7M4HoVSGRk7je9ISdBwla29FIHCgLYoTKI=&uniplatform=NZKPT&language=CHS.
- Bujak R, Struck-Lewicka W, Markuszewski MJ, et al. Metabolomics for laboratory diagnostics. J Pharm Biomed Anal. 2015;113:108–120. doi: 10.1016/j.jpba.2014.12.017.
- Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535(7610):56–64. doi: 10.1038/nature18846.
- Lin Z, Ye W, Zu X, et al. Integrative metabolic and microbial profiling on patients with spleen-yang-deficiency syndrome. Sci Rep. 2018;8(1):6619. doi: 10.1038/s41598-018-24130-7.
- Su G, Wang H, Bai J, et al. A metabonomics approach to drug toxicology in liver disease and its application in traditional chinese medicine. Curr Drug Metab. 2019;20(4):292–300. doi: 10.2174/1389200220666181231124439.
- Tan JY, Tang YC, Huang J. Gut microbiota and lung injury. Adv Exp Med Biol. 2020;1238:55–72. doi:10.1007/978-981-15-2385-4_5.
- Fei WW, Lu ZH, Huang X, et al. Research progress on the correlation of gut microbiota with and pulmonary tuber culosis based on the theory of exterior and interior of lung and large intestine. Chin J Antituberc. 2022;44:500–504. https://kns.cnki.net/kcms2/article/abstract?v=NR7yonmY8oPxZiBGpZA5atVCSB_AzHd9hv9YHqzzMrn5-NHLWDreMWU5LA4oyN7HJfxmDzOEmpPGuzBfjvt8tOIwt4okYKjawjIl8eOqBkAQqgQ7tgelbJDRVU06JubH2vSl-TkZr_nSI_ch3L-yuQ==&uniplatform=NZKPT&language=CHS
- Li L, Yang L. Research advance of microbial communities of lung and intestinal in asthma. China Med. Her. 2022;19:42–45. https://kns.cnki.net/kcms2/article/abstract?v=NR7yonmY8oP3H-j1t4nPpZtClzy1kLDi_rdrl_YLxeh_T2acAHb7fXv6uFrC4RPyX8dTZvVm8jNQv-cH1yIL6pRdHipUp3WEooBA_gITJ82dAszY9OeU-aDIgewlEcYpJJQhVi6JQ1LYbfl-pZmOxg==&uniplatform=NZKPT&language=CHS.
- Konjevod M, Nikolac-Perkovic M, Sáiz J, et al. Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases. J Pharm Biomed Anal. 2021;194:113681. doi: 10.1016/j.jpba.2020.113681.
- Wang Z, Zhao Y. Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell. 2018;9(5):416–431. doi: 10.1007/s13238-018-0549-0.
- Feng YL, Cao G, Chen DQ, et al. Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease. Cell Mol Life Sci. 2019;76(24):4961–4978. doi: 10.1007/s00018-019-03155-9.
- Zhao F, An R, Wang L, et al. Specific gut microbiome and serum metabolome changes in lung cancer patients. Front Cell Infect Microbiol. 2021;11:725284. doi: 10.3389/fcimb.2021.725284.
- Williamson JD, Sadofsky LR, Hart SP. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp Lung Res. 2015;41(2):57–73. doi: 10.3109/01902148.2014.979516.
- Della-Latta V, Cecchettini A, Del-Ry S, et al. Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions. Pharmacol Res. 2015;97:122–130. doi: 10.1016/j.phrs.2015.04.012.
- Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011;208(7):1339–1350. doi: 10.1084/jem.20110551.
- Hofman K, Hall B, Cleaver H, et al. High-throughput quantification of hydroxyproline for determination of collagen. Anal Biochem. 2011;417(2):289–291. doi: 10.1016/j.ab.2011.06.019.
- Organ LA, Duggan AR, Oballa E, et al. Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort. Respir Res. 2019;20(1):148. doi: 10.1186/s12931-019-1118-7.
- Loscertales M, Nicolaou F, Jeanne M, et al. Type IV collagen drives alveolar epithelial-endothelial association and the morphogenetic movements of septation. BMC Biol. 2016;14(1):59. doi: 10.1186/s12915-016-0281-2.
- Garantziotis S, Brezina M, Castelnuovo P, et al. The role of hyaluronan in the pathobiology and treatment of respiratory disease. Am J Physiol Lung Cell Mol Physiol. 2016;310(9):L785–L795. doi: 10.1152/ajplung.00168.2015.
- Zhao HW, Lü CJ, Yu RJ, et al. An increase in hyaluronan by lung fibroblasts: a biomarker for intensity and activity of interstitial pulmonary fibrosis? Respirology. 1999;4(2):131–138. doi: 10.1046/j.1440-1843.1999.00164.x.
- Singer II, Kawka DW, McNally SM, et al. Extensive laminin and basement membrane accumulation occurs at the onset of bleomycin-induced rodent pulmonary fibrosis. Am J Pathol. 1986;125(2):258–268. https://pm.yuntsg.com/details.html?pmid=2431622&key=Extensive%20laminin%20and%20basement%20membrane%20accumulation%20occurs%20at%20the%20onset%20of%20bleomycin-induced%20rodent%20pulmonary%20fibrosis.
- Ren W, Chen Y, Wang Y, et al. Inhibitory effect of pirfenidone on pulmonary fibrosis in patients with acute paraquat poisoning. Am J Transl Res. 2021;13:13192–13199. https://pm.yuntsg.com/details.html?pmid=34956540&key=Inhibitory%20effect%20of%20pirfenidone%20on%20pulmonary%20fibrosis%20in%20patients%20with%20acute%20paraquat%20poisoning.
- Fielding CA, Jones GW, McLoughlin RM, et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity. 2014;40(1):40–50. doi: 10.1016/j.immuni.2013.10.022.
- Zhang WJ, Chen SJ, Zhou SC, et al. Inflammasomes and fibrosis. Front Immunol. 2021;12:643149. doi: 10.3389/fimmu.2021.643149.
- Huang C, Freter C. Lipid metabolism, apoptosis and cancer therapy. Int J Mol Sci. 2015;16(1):924–949. doi: 10.3390/ijms16010924.
- Tager AM, LaCamera P, Shea BS, et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitm ent and vascular leak. Nat Med. 2008;14(1):45–54. doi: 10.1038/nm1685.
- Agudelo CW, Samaha G, Garcia-Arcos I. Alveolar lipids in pulmonary dis ease. A review. Lipids Health Dis. 2020;19(1):122. doi: 10.1186/s12944-020-01278-8.
- Srivastava PK, Misra UK. Phosphatidylcholine metabolism in lung microso mes and lung surfactant of rats exposed intratracheally to coal fly ash. Toxicol Environ Health. 1986;18(3):471–481. doi: 10.1080/15287398609530886.
- Wu G, Bazer FW, Davis TA, et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids. 2009;37(1):153–168. doi: 10.1007/s00726-008-0210-y.
- Krane SM. The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens. Amino Acids. 2008;35(4):703–710. doi: 10.1007/s00726-008-0073-2.
- Wu G, Bazer FW, Burghardt RC, et al. Proline and hydroxyproline metabolism: implications for animal and human nutrition. Amino Acids. 2011;40(4):1053–1063. doi: 10.1007/s00726-010-0715-z.
- Guzy R, Redente EF. Kindlin for the fire: targeting proline synthesis to extinguish matrix production in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2021;65(1):4–5. doi: 10.1165/rcmb.2021-0137ED.
- Baek AR, Hong J, Song KS, et al. Spermidine attenuates bleomycin-induced lung fibrosis by inducing autophagy and inhibiting endoplasmic reticulum stress (ERS)-induced cell death in mice. Exp Mol Med. 2020;52(12):2034–2045. doi: 10.1038/s12276-020-00545-z.
- Bassit RA, Curi R, Costa-Rosa LF. Creatine supplementation reduces plasma levels of pro-inflammatory cytokines and PGE2 after a half-ironman competition. Amino Acids. 2008;35(2):425–431. doi: 10.1007/s00726-007-0582-4.
- Fang YZ, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition. 2002;18(10):872–879. doi: 10.1016/s0899-9007(02)00916-4.
- Whelan J, Fritsche K. Linoleic acid. Adv Nutr. 2013;4(3):311–312. doi: 10.3945/an.113.003772.
- Lynes MD, Leiria LO, Lundh M, et al. The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue. Nat Med. 2017;23(5):631–637. doi: 10.1038/nm.4297.
- Moran JH, Weise R, Schnellmann RG, et al. Cytotoxicity of linoleic acid diols to renal proximal tubular cells. Toxicol Appl Pharmacol. 1997;146(1):53–59. doi: 10.1006/taap.1997.8197.
- Hada M, Edin ML, Hartge P, et al. Prediagnostic serum levels of fatty acid metabolites and risk of ovarian cancer in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2019;28(1):189–197. doi: 10.1158/1055-9965.EPI-18-0392.
- Kim KB, Nam YA, Kim HS, et al. α-linolenic acid: nutraceutical, pharm 19 acological and toxicological evaluation. Food Chem Toxicol. 2014;70:163–178. doi: 10.1016/j.fct.2014.05.009.
- Hamer HM, Jonkers D, Venema K, et al. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27(2):104–119. doi: 10.1111/j.1365-2036.2007.03562.x.
- Hu S, Wang J, Xu Y, et al. Anti-inflammation effects of fucosylated chondroitin sulphate from acaudina molpadioides by altering gut microbiota in obese mice. Food Funct. 2019;10(3):1736–1746. doi: 10.1039/c8fo02364f.
- Ma L, Ni Y, Wang Z, et al. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice. Gut Microbes. 2020;12(1):1–19. doi: 10.1080/19490976.2020.1832857.
- Xia T, Duan W, Zhang Z, et al. Polyphenol-rich vinegar extract regulates intestinal microbiota and immunity and prevents alcohol-induced inflammation in mice. Food Res Int. 2021;140:110064. doi: 10.1016/j.foodres.2020.110064.
- Akay HK, Bahar-Tokman H, Hatipoglu N, et al. The relationship between bifidobacteria and allergic asthma and/or allergic dermatitis: a prospective study of 0-3 years-old children in Turkey. Anaerobe. 2014;28:98–103. doi: 10.1016/j.anaerobe.2014.05.006.
- Mortaz E, Adcock IM, Folkerts G, et al. Probiotics in the management of lung diseases. Mediators Inflamm. 2013;2013:751068. doi: 10.1155/2013/751068.
- Wu T, Sun M, Liu R, et al. Bifidobacterium longum subsp. longum remodeled roseburia and phosphatidylserine levels and ameliorated intestinal disorders and liver metabolic abnormalities induced by high-Fat diet. J Agric Food Chem. 2020;68(16):4632–4640. doi: 10.1021/acs.jafc.0c00717.
- Moon CD, Pacheco DM, Kelly WJ, et al. Reclassification of Clostridium proteoclasticum as Butyrivibrio proteoclasticus comb. nov., a butyrate-producing ruminal bacterium. Int J Syst Evol Microbiol. 2008;58(Pt 9):2041–2045. doi: 10.1099/ijs.0.65845-0.
- Vieira RS, Castoldi A, Basso PJ, et al. Butyrate attenuates lung inflammation by negatively modulating Th9 cells. Front Immunol. 2019;10:67. doi: 10.3389/fimmu.2019.00067.
- Wang L, Wang R, Wei GY, et al. Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice. Biomed Pharmacother. 2020;128:110262. doi: 10.1016/j.biopha.2020.110262.
- Zhou Y, Chen L, Sun G, et al. Alterations in the gut microbiota of patients with silica-induced pulmonary fibrosis. J Occup Med Toxicol. 2019;14(1):5. doi: 10.1186/s12995-019-0225-1.
- Zhai Z, Zhang F, Cao R, et al. Cecropin a alleviates inflammation through modulating the gut microbiota of C57BL/6 mice with DSS-induced IBD. Front Microbiol. 2019;10:1595. doi: 10.3389/fmicb.2019.01595.
- Wan F, Han H, Zhong R, et al. Dihydroquercetin supplement alleviates colonic inflammation potentially through improved gut microbiota community in mice. Food Funct. 2021;12(22):11420–11434. doi: 10.1039/d1fo01422f.
- Li W, Lu L, Liu B, et al. Effects of phycocyanin on pulmonary and gut microbiota in a radiation-induced pulmonary fibrosis model. Biomed Pharmacother. 2020;132:110826. doi: 10.1016/j.biopha.2020.110826.
- Xu X, Shan Q, Ding R, et al. Integrated gut microbiota and serum metabolomics reveal the protective effect of oleanolic acid on liver and kidney-injured rats induced by euphorbia pekinensis. Phytother Res. 2022 Nov 25. doi: 10.1002/ptr.7673.
- Dayama G, Priya S, Niccum DE, et al. Interactions between the gut microbiome and host gene regulation in cystic fibrosis. Genome Med. 2020;12(1):12. doi: 10.1186/s13073-020-0710-2.
- Chiu YC, Lee SW, Liu CW, et al. Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity. PLoS One. 2021;16(4):e0249944. doi: 10.1371/journal.pone.0249944.
- Chen R, Wu P, Cai Z, et al. Puerariae lobatae radix with chuanxiong rhizoma for treatment of cerebral ischemic stroke by remodeling gut microbiota to regulate the brain-gut barriers. J Nutr Biol Chem. 2019;65:101–114. doi: 10.1016/j.jnutbio.2018.12.004.